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Background
Monoclonal antibody 4E10, directed against the MPER
region of gp41, is the most broadly neutralizing antibody
described to date. Only few HIV-1 infected individuals
having 4E10-like Abs in their plasma are identified. Using
phage display peptide libraries, mimotopes of the HIV
envelope epitopes to which antibodies are raised, can be
identified. We investigated an HIV-1 CRF02_AG infected
individual with broad cross-neutralizing antibodies
(BCN), as determined in a pseudovirus (TZMbl) assay.
Methods
M13 phage display peptide libraries (New England
Biolabs) were used to screen BCN plasma of the HIV-1
positive individual, referred to as ITM4, using a stringent
selection strategy. Sequence analysis was performed to
identify HIV-1 specific mimotopes. The mimotopes were
localized in the ITM4-Env sequence.
Results
Phage with a NWFxxTxxLxxx motif were selected. This
mimotope shares key amino acid residues of the 4E10
epitope, and binds HuMAb 4E10. Antibody reactivity to
the 4E10 mimotope was conserved over time (2001–
2007). Pseudovirions were made from 4 different follow
up plasma samples from this patient. The pseudovirions
from earlier time points are sensitive to the MPER-Abs
4E10 and 2F5, in the later ones resistance occurs. Also the
autologous neutralization results suggest a viral escape
from the patient's immune responses. Genetic analysis of
the HIV-1 envelope of the follow up samples revealed no
remarkable changes in the MPER-regions, suggesting
other regions to be responsible for the emerging resist-
ance. The contribution of the 4E10-like Abs to the neutral-
izing capacity of the patient was evaluated using 4E10-
sensitive and 4E10 resistant pseudovirions.
Conclusion
Screening M13 phage display peptide libraries with ITM4
BCN plasma has allowed the identification of antibodies
directed to the 4E10 epitope. The NWFxxTxxLxxx mimo-
tope binds 4E10 antibodies or antibodies sharing the
4E10 epitope. The anti-gp41 Abs seem to contribute to the
broad cross-neutralizing capacity of ITM4.
from AIDS Vaccine 2009
Paris, France. 19–22 October 2009
Published: 22 October 2009
Retrovirology 2009, 6(Suppl 3):P62 doi:10.1186/1742-4690-6-S3-P62
<supplement> <title> <p>AIDS Vaccine 2009</p> </title> <editor>Anna Laura Ross</editor> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1742-4690-6-S3-full.pdf">here</a>.</note> <url>http://www.biomedcentral.com/content/pdf/1471-2105-10-S12-info.pdf</url> </supplement>
This abstract is available from: http://www.retrovirology.com/content/6/S3/P62
© 2009 Dieltjens et al; licensee BioMed Central Ltd. 